Your browser is no longer supported. Please, upgrade your browser.
Settings
OCLS [NASD]
Oculus Innovative Sciences, Inc.
Index- P/E3.44 EPS (ttm)0.21 Insider Own0.10% Shs Outstand14.90M Perf Week-14.05%
Market Cap10.76M Forward P/E- EPS next Y-1.07 Insider Trans72.95% Shs Float14.88M Perf Month-9.75%
Income0.80M PEG- EPS next Q-0.25 Inst Own9.30% Short Float1.64% Perf Quarter-14.56%
Sales12.80M P/S0.84 EPS this Y141.50% Inst Trans56.10% Short Ratio1.02 Perf Half Y-62.00%
Book/sh0.91 P/B0.79 EPS next Y11.60% ROA4.50% Target Price4.00 Perf Year-77.01%
Cash/sh0.15 P/C4.89 EPS next 5Y- ROE6.90% 52W Range0.65 - 3.72 Perf YTD-49.51%
Dividend- P/FCF- EPS past 5Y15.70% ROI-49.20% 52W High-80.59% Beta1.43
Dividend %- Quick Ratio1.10 Sales past 5Y20.50% Gross Margin52.30% 52W Low11.08% ATR0.05
Employees32 Current Ratio1.50 Sales Q/Q-3.00% Oper. Margin-55.50% RSI (14)33.03 Volatility9.42% 6.51%
OptionableNo Debt/Eq0.00 EPS Q/Q-666.70% Profit Margin6.30% Rel Volume0.34 Prev Close0.73
ShortableYes LT Debt/Eq0.00 EarningsMay 14 BMO Payout0.00% Avg Volume240.42K Price0.72
Recom2.00 SMA20-11.34% SMA50-12.93% SMA200-54.74% Volume82,646 Change-1.10%
Apr-19-13Reiterated Maxim Group Buy $2.80 → $6
Dec-14-10Initiated Rodman & Renshaw Mkt Outperform $3
Aug-18-09Initiated Dawson James Buy $4.50
Nov-07-08Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
Aug-06-08Reiterated Rodman & Renshaw Mkt Outperform $14 → $12
Apr-11-08Reiterated Rodman & Renshaw Mkt Outperform $16 → $14
Jul-18-07Reiterated Rodman & Renshaw Mkt Outperform $13 → $16
Jun-21-07Initiated Rodman & Renshaw Mkt Outperform $13
Mar-27-07Initiated Roth Capital Buy $10
Apr-16-15 02:11PM  4 Stocks Under $10 Making Big Moves at TheStreet
08:38AM  Oculus Innovative Sciences Announces Launch of MicrocynAH® Farm and Ranch Animal Healthcare Products at noodls
08:08AM  Oculus Innovative Sciences Announces Launch of MicrocynAH(R) Farm and Ranch Animal Healthcare Products GlobeNewswire
Mar-27-15 12:02PM  Oculus Shares Spike Higher Following WebMD Interview With President Obama On Antibiotic Resistance
Mar-24-15 08:50AM  Andreessen Horowitz invests $20m in UK tech start-up Improbable at Financial Times
Mar-18-15 09:44AM  Oculus Innovative Sciences Banking Millions on Ruthigen-Pulmatrix Merger +6.19%
Mar-16-15 05:16PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements -5.79%
03:31AM  Oculus Innovative Sciences Announces Sale of 350,000 Shares of Ruthigen Stock for $962,500 in Non-Dilutive Funding at noodls
03:05AM  Oculus Innovative Sciences Announces Sale of 350,000 Shares of Ruthigen Stock for $962,500 in Non-Dilutive Funding GlobeNewswire
Mar-12-15 04:32PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Ru
Mar-07-15 03:56PM  Suddenly, everyone's making computers you strap to your face. Here's a rundown of all the big players.
Mar-06-15 10:00PM  [$$] Googles Android to Take On Facebook in Virtual Reality at The Wall Street Journal
05:01PM  I tried both of the two hottest virtual reality headsets this week here's why Vive beats Oculus
Mar-04-15 01:00PM  I just had the most mind-blowing virtual reality experience ever +5.81%
08:49AM  Oculus VR hires Google X exec Mary Lou Jepsen at San Jose Mercury News
Mar-03-15 12:48PM  Oculus VR hires Google X exec Mary Lou Jepsen at Los Angeles Times
12:47PM  AMD's LiquidVR Technology Signals New Battleground For The GPU Wars at Forbes
12:34PM  Sony Woos Game Makers to Bring Along Virtual Reality at Bloomberg
09:15AM  Oculus Innovative Sciences Announces New Animal Healthcare Division and Launch of MicrocynAH® Advanced All-Animal Healthcare Products at noodls
Mar-02-15 07:41PM  Google X exec jumps to Oculus here's the talk she gave at Google when she was hired Business Insider
08:36AM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
12:44AM  HTC Takes on Sony With Headset That Lets You Roam Virtual Worlds Bloomberg
12:00AM  Sony Woos Game Makers to Ensure Demand for Virtual Reality Gear Bloomberg
Mar-01-15 05:15PM  HTC takes on Facebook in virtual reality wars at CNBC
Feb-27-15 10:46AM  Oculus Innovative Sciences No One Trick Pony With Launch of New Animal Healthcare Division
Feb-26-15 08:08AM  Oculus Innovative Sciences Announces New Animal Healthcare Division and Launch of MicrocynAH(R) Advanced All-Animal Healthcare Products GlobeNewswire
Feb-25-15 05:35PM  Oculus offers $1 million prize pool for Gear VR developers at Engadget +5.84%
Feb-24-15 12:29PM  Meet Facebook's new virtual reality competitor at CNBC -9.22%
Feb-20-15 07:00AM  5 Stocks Ready for Breakouts: Juno Therapeutics, Cheetah Mobile and More at TheStreet +8.69%
Feb-19-15 01:04PM  OCULUS INNOVATIVE SCIENCES, INC. Financials EDGAR Online Financials
Feb-18-15 08:43AM  Time to Take Another Look at Oculus Innovative Sciences Company Spotlight
Feb-14-15 07:07PM  10-Q for Oculus Innovative Sciences, Inc. Company Spotlight
Feb-12-15 04:30PM  Oculus Innovative Sciences Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:05PM  Oculus Innovative Sciences Reports Financial Results for the Third Quarter of Fiscal Year 2015 GlobeNewswire
04:03PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Jan-29-15 05:05AM  Oculus Innovative Sciences Announces Fiscal Third Quarter 2015 Financial Results and Conference Call GlobeNewswire
Jan-26-15 05:50PM  Oculus Innovative Sciences Announces Closing of $6.3 Million Underwritten Public Offering GlobeNewswire
05:04PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financ EDGAR Online
Jan-21-15 06:01PM  Nasdaq stocks posting largest volume increases AP -27.46%
11:25AM  Oculus Innovative Sciences Plummets Nearly 30% Following Stock Offering Announcement Benzinga
09:00AM  Oculus Innovative Sciences Announces Pricing of Upsized $6.3 Million Underwritten Public Offering GlobeNewswire
Jan-12-15 06:02AM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements EDGAR Online
05:05AM  Oculus Innovative Sciences Enters Into Agreement to Sell Ruthigen, Inc. Shares for $5.5 Million in Event of Ruthigen Merger GlobeNewswire
Jan-09-15 10:54AM  When will virtual reality games hit stores? at Fortune
Jan-07-15 05:05AM  Oculus Innovative Sciences Announces New Dermatology Division, IntraDerm Pharmaceuticals GlobeNewswire
Dec-18-14 08:08AM  NVN Therapeutics Launches EstraCool(TM) Dietary Supplement for Reduction of Menopausal Symptoms GlobeNewswire
Dec-08-14 04:48PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, EDGAR Online
Nov-15-14 07:07PM  10-Q for Oculus Innovative Sciences, Inc. Company Spotlight
Nov-13-14 04:06PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme EDGAR Online
04:05PM  Oculus Innovative Sciences Reports Financial Results for the Second Quarter of Fiscal Year 2015 GlobeNewswire
Nov-11-14 05:05AM  Oculus Innovative Sciences Commercializes Microcyn(R)-Based Solution and Hydrogel for Treatment of Mild-to-Moderate Acne in Europe GlobeNewswire
Nov-04-14 05:00AM  Oculus Innovative Sciences Receives European CE Mark for New Microcyn(R)-Based Scar Management Hydrogel GlobeNewswire
Oct-30-14 11:30AM  Soaring costs of competing in the global internet race at Financial Times
10:29AM  Dilemma: Should companies reinvest or buyback stock? at CNBC
08:12AM  Oculus Innovative Sciences Receives European CE Mark for New Microcyn(R)-Based Atopic Dermatitis Hydrogel GlobeNewswire
08:08AM  Oculus Innovative Sciences Announces Fiscal Second Quarter 2015 Financial Results and Conference Call GlobeNewswire
Sep-21-14 01:30PM  Science fiction a step closer as Oculus virtual reality headsets near release at Financial Times
Sep-16-14 08:08AM  Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Allowance of Four New Patents for Microcyn(R) Technology GlobeNewswire
Sep-12-14 04:12PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Sep-10-14 08:08AM  Oculus Innovative Sciences Introduces Microcyn(R)-Based Over-the-Counter Advanced Scar Management Hydrogel in United States GlobeNewswire
Aug-12-14 04:15PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Aug-07-14 04:20PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme EDGAR Online
04:05PM  Oculus Innovative Sciences Reports Revenues of $3.4 Million and Net Loss of $70,000 for First Quarter of Fiscal 2015 GlobeNewswire
Aug-01-14 04:27PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Jul-24-14 08:08AM  Oculus Innovative Sciences Announces Fiscal First Quarter 2015 Financial Results and Conference Call GlobeNewswire
Jun-30-14 04:31PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 10-K, Annual Report EDGAR Online
Jun-26-14 06:42PM  Ruthigen Poised To Hit It Out Of The Park at Seeking Alpha
Jun-16-14 11:15AM  Oculus Innovative Sciences Inc Stock Upgraded (OCLS) at TheStreet
Jun-13-14 10:08AM  [video] 10 exciting video games to look out for at CNBC -7.60%
Jun-12-14 05:06PM  Why Oculus Innovative Sciences (OCLS) Stock Is Lower In After-Hours Trading at TheStreet
05:01PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme EDGAR Online
04:05PM  Oculus Innovative Sciences Reports Revenues of $2.9 Million and Net Income of $7.5 Million for Fourth Quarter of Fiscal 2014 Primarily Due to Accounting Treatment of Ruthigen IPO Transaction GlobeNewswire
May-29-14 08:08AM  Oculus Innovative Sciences Announces Fiscal Fourth Quarter 2014 Financial Results and Conference Call GlobeNewswire
May-07-14 08:08AM  NVN Therapeutics Launches Glucorein(TM) HOP Reproductive Support Dietary Supplement for Women GlobeNewswire
Apr-30-14 06:40PM  Temper Dow Growth Optimism on Volume Concerns at TheStreet
Apr-28-14 05:13PM  What a Dizzying Day in the Markets at TheStreet
Apr-22-14 08:08AM  Oculus Innovative Sciences' Partner, More Pharma, Launches Microcyn(R)-Based Oral and Throat Infection Treatment Product in Mexico GlobeNewswire
Apr-09-14 08:08AM  Oculus Innovative Sciences Receives 'Strong Consensus' Rating for Use With Kinetic Concepts' Negative Pressure Wound Therapy With Instillation GlobeNewswire
Apr-02-14 04:55PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements EDGAR Online
08:08AM  Oculus Innovative Sciences Announces Board of Directors Restructuring Following Ruthigen IPO GlobeNewswire
Apr-01-14 05:05PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financi EDGAR Online +7.16%
Mar-27-14 08:20AM  Oculus appoints Cytokinetics CFO Sharon Barbari to board at theflyonthewall.com -9.19%
08:08AM  Oculus Innovative Sciences Announces Appointment of Sharon Barbari to Its Board of Directors GlobeNewswire
Mar-26-14 02:42PM  Why Oculus Innovative Sciences (OCLS) Stock Is Up Today at TheStreet +5.51%
02:36PM  Oculus strength attributed to confusion over Facebook acquisition at theflyonthewall.com
02:16PM  Midday movers: King Digital, Garmin, Corning & More at CNBC
12:52PM  A case of mistaken identity sends another Oculus soaring at MarketWatch
12:41PM  What's in the name Oculus? at Financial Times
12:19PM  On The Fly: Midday Wrap at theflyonthewall.com
12:02PM  Whoops! Stocks with Oculus name spike at CNNMoney.com
12:00PM  [video] Tech Yeah! Facebook moves into virtual reality at CNBC
11:30AM  Oculus Shares Up 152%, But It's Not That Oculus at The Wall Street Journal
11:25AM  Virtual Confusion: Unrelated Oculus Companies Rally on Facebook Buy at Fox Business
11:15AM  Oops! Wrong Oculus shares skyrocket at CNBC
10:49AM  Oculus strength attributed to confusion over Facebook acquisition at theflyonthewall.com
10:06AM  Two Stocks That Sound Like Oculus Are Going Bonkers For Some Reason Business Insider
Mar-25-14 05:06PM  [video] Facebook acquires Oculus for $2 billion at CNBC -6.78%
Mar-21-14 06:03PM  Nasdaq stocks posting largest percentage decreases AP -11.99%
Mar-17-14 01:09PM  Why Oculus Could Trade Higher Within 2 Weeks at Seeking Alpha +12.84%
Mar-14-14 01:25PM  5 Stocks Poised for Breakouts at TheStreet +9.27%
Oculus Innovative Sciences, Inc. designs, produces, and markets prescription and non-prescription products based on its Microcyn platform technology for the dermatology, surgical, advanced wound and tissue care, and animal healthcare markets in the United States, Mexico, Europe, and internationally. The Microcyn platform technology is based on electrically charged oxychlorine small molecules, which are designed to target a range of organisms that cause disease, including viruses, fungi, spores, and antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus, as well as Clostridium difficile, a highly contagious bacteria spread by human contact. It offers Microcyn-based human advanced wound and tissue care products as prescription and over-the-counter products; and Microcyn technology-based animal healthcare products under the Vetericyn brand. The company's Microcyn has received eight 510(k) clearances for use as a medical device in wound care management, including for acute and chronic wounds, and in dermatology applications. In addition, it provides consulting and laboratory services to medical companies that design and manufacture biomedical devices and drugs. Oculus Innovative Sciences, Inc. sells its products directly, and through contract sales organization and distributors to hospitals, physicians, nurses, and other healthcare practitioners, as well as to dermatologists for the treatment of various skin afflictions. The company was formerly known as Micromed Laboratories, Inc. and changed its name to Oculus Innovative Sciences, Inc. in August 2001. Oculus Innovative Sciences, Inc. was incorporated in 1999 and is headquartered in Petaluma, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schutz James JChief Executive OfficerNov 17Buy1.786,28511,18720,885Nov 17 04:31 PM